Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Gains from Sales and Divestitures (2020 - 2024)

Relay Therapeutics (RLAY) has disclosed Gains from Sales and Divestitures for 4 consecutive years, with $2.1 million as the latest value for Q4 2024.

  • Quarterly Gains from Sales and Divestitures changed N/A to $2.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2024, changed N/A year-over-year, with the annual reading at $2.1 million for FY2024, N/A changed from the prior year.
  • Gains from Sales and Divestitures for Q4 2024 was $2.1 million at Relay Therapeutics, up from $398330.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $2.1 million in Q4 2024, with the low at $75875.0 in Q4 2021.
  • Average Gains from Sales and Divestitures over 4 years is $794839.0, with a median of $489077.5 recorded in 2020.
  • The sharpest move saw Gains from Sales and Divestitures tumbled 86.91% in 2021, then skyrocketed 424.98% in 2022.
  • Over 4 years, Gains from Sales and Divestitures stood at $579825.0 in 2020, then crashed by 86.91% to $75875.0 in 2021, then surged by 424.98% to $398330.0 in 2022, then soared by 433.56% to $2.1 million in 2024.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $2.1 million, $398330.0, and $75875.0 for Q4 2024, Q4 2022, and Q4 2021 respectively.